Finance

Lists
Why is RADX down 10.56%?
Dive Deeper
RADX:NASDAQ
RADIOPHARM THERANOSTICS ADR
$1.27
-10.56%
(-0.15) 1D
$1.08
-14.96% (-0.19)
After hours
Closed: Oct 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RADX...
Open
$1.39
High
$1.40
Low
$1.00
Mkt. cap
19.79M
Avg. vol.
62.01K
Volume
82.30K
52-wk high
$16.25
52-wk low
$1.00
Shares outstanding
15.70M
No. of employees
14
Open
$1.39
High
$1.40
Low
$1.00
Mkt. cap
19.79M
Avg. vol.
62.01K
Volume
82.30K
52-wk high
$16.25
52-wk low
$1.00
Shares outstanding
15.70M
No. of employees
14
News stories
From web sources and news partners
About RADIOPHARM THERANOSTICS ADR
CEO-
Employees14
Founded2021
Headquarters-
SectorBiotechnology
Websiteradiopharmtheranostics.com
Analyst
Recommendation
Action
Price target
Projected
Date
Robert Burns
H.C. Wainwright
Buy
Initiated
$16.00
+1,159.8%
06/04/2026
Michael Okunewitch
Maxim Group
Buy
Maintained
$15.00
+1,081.1%
03/25/2026
Justin Walsh
JonesTrading
Buy
Reiterated
$30.00
+2,262.2%
03/25/2026
Yuan Zhi
B. Riley Securities
Buy
Maintained
$16.00
+1,159.8%
12/16/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.10M
3.10M
3.33M
3.33M
Cost of goods sold
11.30M
11.30M
12.30M
12.30M
Cost of revenue
11.30M
11.30M
12.30M
12.30M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.18M
4.18M
3.92M
3.92M
Operating expense
4.95M
4.95M
4.36M
4.36M
Total operating expenses
16.25M
16.25M
16.67M
16.67M
Operating income
-13.14M
-13.14M
-13.33M
-13.33M
Other non operating income
-
-
-
-
EBT including unusual items
-14.05M
-14.05M
-14.39M
-14.39M
EBT excluding unusual items
-13.37M
-13.37M
-13.18M
-13.18M
Income tax expense
67.15K
67.15K
-39.93K
-39.93K
Effective tax rate
-0.48%
-0.48%
0.28%
0.28%
Other operating expenses
-
-
-
-
Net income
-13.48M
-13.48M
-14.99M
-14.99M
Net profit margin
-434.67%
-434.67%
-450.12%
-450.12%
Earnings per share
-
-
-
-
Interest and investment income
-
-
318.57K
318.57K
Interest expense
-32.55K
-32.55K
-23.64K
-23.64K
Net interest expenses
-32.55K
-32.55K
294.93K
294.93K
Depreciation and amortization charges
-
-
-
-
EBITDA
-12.47M
-12.47M
-12.66M
-12.66M
Gain or loss from assets sale
-
-
106.38K
106.38K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps